InsidersTradesSigma
Follow the 伟思医疗 share price and the full directors' dealings record of the company, a listed issuer based in China. Shares trade on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 伟思医疗 has recorded 10 public disclosures. Market capitalisation: €4.7bn. The latest transaction was disclosed on 17 July 2026 (Purchase). Among the most active insiders: 高飞. Every trade is free.
10
Insider Decl.
n/a
Thresholds
€50,463
3 ops.
Buy Volume
€254,456
7 ops.
Sell Volume
18Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 8,896 of 29,063 companies
61.2
score / 100
Value39
Quality84
FCF yld1.3%
Earn yld3.1%
EV/EBITDA24.0x
ROE9.7%
Gross mgn66%
Net mgn30%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 17 July 2026
Declarations10 total
10 of 10 declarations
关于 伟思医疗
伟思医疗是一家在医疗保健和制药领域运营的公司，在上海证券交易所上市。该公司专注于创新医疗解决方案的开发和商业化。